Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

BioPharma APAC
biopharmaapac.com > news > 17 > 8345 > lkahi-therapeutics-expands-ai-futures-lab-collaboration-with-university-of-georgia.html

Lōkahi Therapeutics Expands ai² Futures Lab Collaboration with University of Georgia

7+ hour, 6+ min ago   (133+ words) 24 August 2026 | Monday | News During its first year, the ai² Futures Lab™ engaged 64 students and identified more than 45 potential acquisition assets. Several of these advanced into active pipeline discussions, demonstrating how the program expands Lōkahi’s sourcing reach and analytical capacity while supporting…...

BioPharma APAC
biopharmaapac.com > news > 47 > 8341 > us-fda-grants-breakthrough-therapy-and-fast-track-designations-to-norroys-68ga-nym096-for-kidney-cancer-imaging.html

US FDA Grants Breakthrough Therapy and Fast Track Designations to NORROY’s 68Ga-NYM096 for Kidney Cancer Imaging

3+ day, 7+ hour ago   (142+ words) 21 August 2026 | Friday | News 68Ga-NYM096 is the first China-originated innovative radiopharmaceutical to receive FDA Breakthrough Therapy Designation. It is being developed as a non-invasive PET imaging agent to enable the characterization of indeterminate renal masses identified by Computed Tomography (CT) or Magnetic…...

BioPharma APAC
biopharmaapac.com > news > 31 > 8338 > ingenia-therapeutics-debuts-on-kosdaq-to-accelerate-next-gen-vascular-antibody-pipeline.html

Ingenia Therapeutics Debuts on KOSDAQ to Accelerate Next-Gen Vascular Antibody Pipeline

3+ day, 7+ hour ago   (98+ words) 21 August 2026 | Friday | News Leveraging IPO proceeds, Ingenia is expediting clinical development across its broader pipeline: "Going public on KOSDAQ is a transformative milestone for Ingenia as we lead a paradigm shift in vascular disease treatments," said Sangyeul Han, PhD, CEO…...

BioPharma APAC
biopharmaapac.com > news > 54 > 8333 > intuitive-to-establish-316000-sq-ft-robotic-surgery-manufacturing-facility-in-penang.html

Intuitive to Establish 316,000-Sq-Ft Robotic Surgery Manufacturing Facility in Penang

4+ day, 21+ hour ago   (216+ words) 19 August 2026 | Wednesday | News (From left to right): Mark Brosius, Executive Vice President, Chief Manufacturing and Supply Chain Officer, Intuitive, YB Sim, Deputy Minister of Investment, Trade and Industry, Malaysia; the Right Honourable Chow Kon Yew, Chief Minister of Penang and…...

BioPharma APAC
biopharmaapac.com > news > 70 > 8328 > singapore-launches-first-biological-data-centre-prototype-to-advance-energy-efficient-ai-computing.html

Singapore Launches First Biological Data Centre Prototype to Advance Energy-Efficient AI Computing

6+ day, 1+ hour ago   (389+ words) 18 August 2026 | Tuesday | News The prototype was launched in the presence of the public sector, representatives from academia, the technology, and digital infrastructure sectors. Delegates viewed a live demonstration of Cortical Labs' CL1 biological computing system and toured the NUS laboratory supporting…...

BioPharma APAC
biopharmaapac.com > news > 34 > 8327 > henlius-sandoz-expand-global-biosimilars-alliance-with-up-to-10-new-antibody-assets.html

Henlius, Sandoz Expand Global Biosimilars Alliance with Up to 10 New Antibody Assets

5+ day, 22+ hour ago   (79+ words) 18 August 2026 | Tuesday | News In April 2025, the two companies entered into an exclusive commercialization partnership for HLX13, Henlius' proposed ipilimumab biosimilar, across 46 countries and regions including Europe and the United States. This new agreement further deepens the existing oncology biosimilars collaboration between…...

BioPharma APAC
biopharmaapac.com > news > 89 > 8319 > thermo-fisher-scientific-and-kyan-technologies-sign-mou-to-advance-functional-precision-oncology-for-solid-tumours.html

Thermo Fisher Scientific and KYAN Technologies Sign MoU to Advance Functional Precision Oncology for Solid Tumours

1+ week, 1+ day ago   (177+ words) 14 August 2026 | Friday | News Thermo Fisher Scientific and KYAN Technologies have signed a Memorandum of Understanding (MoU) to collaborate on advancing functional precision oncology approaches for solid tumours. Bringing these capabilities together could provide a more comprehensive view of individual tumour…...

BioPharma APAC
biopharmaapac.com > news > 32 > 8317 > insilico-nominates-ai-designed-ism0900-as-preclinical-candidate-for-cardiovascular-risk.html

Insilico Nominates AI-Designed ISM0900 as Preclinical Candidate for Cardiovascular Risk

1+ week, 2+ day ago   (163+ words) 14 August 2026 | Friday | News In preclinical studies, ISM0900 demonstrates potent and selective inhibition of Lp(a) assembly at nanomolar-level activity, along with more rapid onset in animal models, excellent oral pharmacokinetic properties, and superior efficacy compared to clinical-stage candidates of the same class....

BioPharma APAC
biopharmaapac.com > news > 47 > 8315 > arkbios-long-acting-influenza-candidate-ak0406-secures-ind-approval-in-china.html

ArkBio’s Long-Acting Influenza Candidate AK0406 Secures IND Approval in China

1+ week, 3+ day ago   (143+ words) 14 August 2026 | Friday | News Shanghai Ark Biopharmaceutical Co., Ltd. announced that the Investigational New Drug (IND) application for AK0406 injection, the company's first long-acting antiviral drug‑Fc conjugate (AFC) candidate for influenza prophylaxis, has been approved by the National Medical Products Administration…...

biopharmaapac.com
biopharmaapac.com > news > 18 > 8318 > singhealth-launches-global-fellowship-network-to-develop-future-ready-healthcare-leaders.html

SingHealth Launches Global Fellowship Network to Develop Future-Ready Healthcare Leaders

1+ week, 3+ day ago   (260+ words) 14 August 2026 | Friday | News Building a Global Community of Future-Ready Healthcare Leaders Through the Network, selected administrators will undertake a structured programme of six to eight weeks in one of these institutions across North America, Europe and Asia. Together with SingHealth,…...